| | United States Patent Application: 0030148980 |
 | | A hybrid oligonucleotide phosphorothioate or phosphorodithioate according to claim 1, having an oligonucleotide sequence that is complementary to a nucleic acid sequence from a virus, a pathogenic organism, or a cellular gene. |
 | | A hybrid oligonucleotide phosphorothioate or phosphorodithioate according to claim 2, having an oligonucleotide sequence that is complementary to a nucleic acid sequence from a virus, a pathogenic organism, or a cellular gene. |
 | | Oligonucleotides according to this aspect of the invention share the characteristics of the above-described oligonucleotides, except that the oligonucleotide sequence of oligonucleotides according to this aspect of the invention is complementary to a nucleic acid sequence that is from a virus, a pathogenic organism or a cellular gene. |
| appft1.uspto.gov /netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1="20030045494".PGNR.&OS=DN/20030045494&RS=DN/20030045494 (5031 words) |